Evonik producing CDT and polyamide 12 without any limitations

February 26, 2013

As recently as ten months after the fire in Evonik Industries’, cyclododecatriene (CDT) plant, CDT-based VESTAMID® products and its precursors are available once again without limitations, thus force majeure ceased. After the reconstructed plant resumed operations at the Marl site in December, it demonstrated in early February how well it can run under normal operating conditions. This was done by subjecting the plant to a 72-hour test at full capacity. The VESTAMID® grades based on CDT as a raw material are thus available again in full quantities.

“With a construction period of only six months, we’ve succeeded in minimizing the fallout time for CDT as much as possible after the plant explosion and fire;” says Gregor Hetzke, president of the Performance Polymers Business Unit, looking back at the successful efforts of the past year. Reconstruction to the CDT plant was begun in June, followed by its mechanical completion in November.

CDT is a raw material for producing premium plastics, above all, polyamide 12, which is used by the automobile industry, for example.

Downloads

Contact

Dr. Ursula Keil

High Performance Polymers

  • Corporate information

    Evonik, the creative industrial group from Germany, is one of the world’s leading specialty chemicals companies. Profitable growth and a sustained increase in the value of the company form the heart of our strategy. Our activities focus on the key megatrends health and nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

    Evonik is active in over 100 countries around the world. In fiscal 2011 more than 33,000 employees generated sales of around €14.5 billion and an operating profit (EBITDA) of about €2.8 billion.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.